Who owns TRAVERE THERAPEUTICS INC (TVTX?
- CUSIP Number: 89422gaa5
Tip: Access positions for across all investors
Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Travere Therapeutics stock
Who bought or sold TRAVERE THERAPEUTICS INC (TVTX this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Linden Advisors | 91M | $102M | -4% | Sep 2025 |
|
| D. E. Shaw & Co | 43M | $49M | -5% | Sep 2025 |
|
| Graham Capital Management | 22M | $25M | -47% | Sep 2025 |
|
| Advent Capital Management | 14M | $20M | -30% | Dec 2025 |
|
| Millennium Management | 13M | $15M | 100% | Sep 2025 |
|
| Lord, Abbett & Co | 12M | $14M | 30% | Sep 2025 |
|
| Point72 Asset Management | 10M | $11M | 100% | Sep 2025 |
|
| Oaktree Capital Management | 9.2M | $10M | 19% | Sep 2025 |
|
| Agf Management | 8.8M | $9.9M | -37% | Sep 2025 |
|
| Polar Capital Holdings | 8.0M | $8.9M | 167% | Sep 2025 |
|
| Affinity Asset Advisors | 7.0M | $7.9M | 0% | Sep 2025 |
|
| Shenkman Capital Management | 6.7M | $9.8B | 7% | Dec 2025 |
|
| Henderson Group | 6.4M | $7.2M | 100% | Sep 2025 |
|
| Goldman Sachs Group | 5.9M | $8.4M | 266% | Dec 2025 |
|
| FMR | 3.8M | $4.2M | -7% | Sep 2025 |
|
| BlackRock | 3.2M | $3.6M | 0% | Sep 2025 |
|
| Gabelli Funds | 2.4M | $3.4M | 100% | Dec 2025 |
|
| Kohlberg Kravis Roberts & Co | 2.0M | $2.3M | 145% | Sep 2025 |
|
| Toronto-Dominion Bank | 811k | $925k | -68% | Sep 2025 |
|
| New York State Common Retirement Fund | 800k | $1.1M | -60% | Dec 2025 |
|
| Jpmorgan Chase & Co | 556k | $634k | 100% | Sep 2025 |
|
| GAMCO Asset Management | 250k | $352k | 100% | Dec 2025 |
|
| Barclays | 155k | $221k | 100% | Dec 2025 |
|
| Context Capital Management | 46k | $53M | 22% | Sep 2025 |
|
| Branch Banking & Trust Company | 41k | $58k | 0% | Dec 2025 |
|
| Stonegate Investment Group | 25k | $28k | 0% | Sep 2025 |
|
| Goss Wealth Management | 21k | $30k | 100% | Dec 2025 |
|
| Wiley Bros.-aintree Capital | 16k | $18k | 100% | Sep 2025 |
|
| Insigneo Advisory Services | 13k | $15k | 0% | Sep 2025 |
|
| Leucadia National Corporation | 11k | $16k | 100% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 2.0k | $2.3k | 100% | Sep 2025 |
|
Who sold out of Travere Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jump Financial | Jun 2025 | 8.0M | $7.7M |
| Wealth Enhancement Advisory Services | Sep 2025 | 10k | $12k |